Product Information
SUCRALFATE 1 GM TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.1727 per EA under NDC 60219165601. Its NADAC has been published 104 times since Oct 9, 2024.
FDA first approved this application on Apr 15, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
60219165601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SUCRALFATEApproval Type
Generic (ANDA)
FDA Application
ANDA215576FDA Approved
4/15/2022
TE Code
AB
On Market Since
3/2/2024
Pharmacological Classes
Price Statistics
The NADAC for SUCRALFATE 1 GM TABLET has been published 104 times since Oct 9, 2024, and over the history we have for it it has declined 6.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1727 per EA |
|---|---|
| All-time high | $0.1905 (Apr 15, 2026) |
| All-time low | $0.1563 (Nov 20, 2024) |
| 52-week high | $0.1905 |
| 52-week low | $0.1725 |
| Median price | $0.1820 |
| Average price | $0.1796 |
| Largest weekly change | -11.6% (Nov 20, 2024) |
| Weeks tracked | 104 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sucralfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aluminum Complex class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUCRALFATE 1 GM TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $0.1727 per EA (NDC 60219165601), effective Sep 30, 2026.
How has the price of SUCRALFATE 1 GM TABLET changed over time?
Over the history we have for it, the NADAC for SUCRALFATE 1 GM TABLET has declined 6.7%. It has been tracked across 104 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM TABLET?
Since Oct 9, 2024, the NADAC for SUCRALFATE 1 GM TABLET has ranged from a low of $0.1563 (Nov 20, 2024) to a high of $0.1905 (Apr 15, 2026), with a median of $0.1820 per EA.
Are there cheaper alternatives to SUCRALFATE 1 GM TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SUCRALFATE 1 GM TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SUCRALFATE 1 GM TABLET?
SUCRALFATE 1 GM TABLET (NDC 60219165601) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.